Lourdes Gimeno Arias

Sanguansook P, Rodprasert W, Sawangmake C, Gimeno L, Ferran JL, Soria-Monzo P, Aviles M, Izquierdo Rico MJ, Chatdarong K. Expression of IZUMO1 and JUNO in the gonads of domestic cats (Felis catus). Theriogenology. 2024 Mar 1;220:70-76. doi: 10.1016/j.theriogenology.2024.02.032. Online ahead of print. PubMed PMID: 38484673.

AÑO: 2024; IF: 2.8

38484673

Gimeno L, González-Lozano I, Soto-Ramírez MF, Martínez-Sánchez MV, López-Cubillana P, Fuster JL, Martínez-García J, Martínez-Escribano J, Campillo JA, Pons-Fuster E, Ferri B, López-Abad A, Muro M, Minguela A. CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients. Oncoimmunology. 2021 Oct 14;10(1):1986943. doi: 10.1080/2162402X.2021.1986943. eCollection 2021. PubMed PMID: 34676148; PubMed Central PMCID: PMC8525952.

AÑO: 2021; IF: 7.723

34676148

Minguela A, Vasco-Mogorrón MA, Campillo JA, Cabañas V, Remigia MJ, Berenguer M, García-Garay MC, Blanquer M, Cava C, Galian JA, Gimeno L, Soto-Ramírez MF, Martínez-Hernández MD, de la Rubia J, Teruel AI, Muro M, Periago A. Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment. Am J Cancer Res. 2021 Sep 15;11(9):4438-4454. eCollection 2021. PubMed PMID: 34659897; PubMed Central PMCID: PMC8493371.

AÑO: 2021; IF: 5.942

34659897

Bernal E, Gimeno L, Alcaraz MJ, Quadeer AA, Moreno M, Martínez-Sánchez MV, Campillo JA, Gomez JM, Pelaez A, García E, Herranz M, Hernández-Olivo M, Martínez-Alfaro E, Alcaraz A, Muñoz Á, Cano A, McKay MR, Muro M, Minguela A. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019. J Infect Dis. 2021 Jul 15;224(2):229-240. doi: 10.1093/infdis/jiab228. PubMed PMID: 33928374; PubMed Central PMCID: PMC8135764.

AÑO: 2021; IF: 7.759

33928374

Vasco-Mogorrón MA, Campillo JA, Periago A, Cabañas V, Berenguer M, García-Garay MC, Gimeno L, Soto-Ramírez MF, Martínez-Hernández MD, Muro M, Minguela A. Proliferation to Apoptosis Tumor Cell Ratio as a Biomarker to Improve Clinical Management of Pre-Malignant and Symptomatic Plasma Cell Neoplasms. Int J Mol Sci. 2021 Apr 9;22(8). pii: 3895. doi: 10.3390/ijms22083895. PubMed PMID: 33918790; PubMed Central PMCID: PMC8068942.

AÑO: 2021; IF: 6.208

33918790